Medical devices, healthcare technology and the business of care
510(k) clearance · K261961

Ntegrate Threaded Nail System

Nvision Biomedical Technologies · Decision date Oct 14, 2026

MEDTECHLEDGER EXPLANATIONK261961

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 14 October 2026 for the Ntegrate Threaded Nail System, submitted by Nvision Biomedical Technologies of San Antonio, Texas, under 510(k) number K261961. The filing was received on 11 June 2026 and reviewed as a traditional 510(k) by the Orthopedic panel; it was not reviewed by a third party, was not a combination product, and no predetermined change control plan was authorized.

The device falls under regulation 888.3040 with classification product code HWC, described on the record as a bone fixation screw, in the orthopedic specialty. A substantially equivalent decision means the submission was cleared to market; it is not a PMA approval. The record does not state which predicate device was cited, what components or design changes distinguish this system, or what nonclinical or clinical evidence supported the decision, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261961
Regulatory pathway
510(k) premarket notification
Product code
HWC
Decision code
SESE
Decision date
Oct 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Screw, Fixation, Bone.

Product code
HWC
FDA device class
2

FDA decision timeline

  1. K261961 received

    Application receipt date recorded by FDA.

  2. K261961 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HWC

Product / regulatory recordCompanyPathwayDecision dateSource
GM Dos Reis Industria e Comercio Ltda.510(k) clearanceNov 2, 2026FDA
OsteoCentric Technologies510(k) clearanceOct 2, 2026FDA
ARTHREX, INC.510(k) clearanceSep 25, 2026FDA
MEDSHAPE, INC.510(k) clearanceSep 23, 2026FDA
Steps Ortho510(k) clearanceSep 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Nvision Biomedical Technologies

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Antonio, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records